Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Mersana Therapeutics (MRSN) stocks in Canada
Learn how to easily invest in Mersana Therapeutics stocks.
Mersana Therapeutics is a biotechnology business based in the US. Mersana Therapeutics stocks (MRSN.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $12.85 – an increase of 17.11% over the previous week. Mersana Therapeutics employs 169 staff and has a trailing 12-month revenue of around $2.1 million.
How to buy stocks in Mersana Therapeutics
- Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – MRSN – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Mersana Therapeutics?
- Has coronavirus impacted Mersana Therapeutics shares?
- Mersana Therapeutics shares summary
- Compare share dealing platforms
- Is Mersana Therapeutics stock a buy or sell?
- Mersana Therapeutics performance over time
- Mersana Therapeutics's financials
- How volatile are Mersana Therapeutics shares?
- Does Mersana Therapeutics pay a dividend?
- Other common questions
Mersana Therapeutics stock price (NASDAQ:MRSN)Use our graph to track the performance of MRSN stocks over time.
Mersana Therapeutics shares at a glance
|Latest market close||$3.49|
|52-week range||$2.68 - $15.34|
|50-day moving average||$3.92|
|200-day moving average||$6.90|
|Wall St. target price||$18.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-2.49|
Compare stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Mersana Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Mersana Therapeutics price performance over time
|1 week (2022-05-12)||22.89%|
|1 month (2022-04-22)||-9.35%|
|3 months (2022-02-18)||N/A|
|6 months (2021-11-22)||-54.08%|
|1 year (2021-05-21)||-75.16%|
|2 years (2020-05-22)||-64.75%|
|3 years (2019-05-22)||4.94|
|5 years (2017-05-18)||N/A|
Mersana Therapeutics financials
|Revenue TTM||$2.1 million|
|Gross profit TTM||$-131,970,000|
|Return on assets TTM||-44.65%|
|Return on equity TTM||-107.91%|
|Market capitalisation||$334.6 million|
TTM: trailing 12 months
Mersana Therapeutics share dividends
We're not expecting Mersana Therapeutics to pay a dividend over the next 12 months.
Mersana Therapeutics share price volatility
Over the last 12 months, Mersana Therapeutics's shares have ranged in value from as little as $2.68 up to $15.34. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Mersana Therapeutics's is 2.3477. This would suggest that Mersana Therapeutics's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Mersana Therapeutics overview
Mersana Therapeutics, Inc. , a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also develops XMT-1660, a B7-H4-targeted Dolasynthen ADC candidate; and XMT-2056, an immunosynthen development candidate. It has a strategic research and development partnerships with Merck KGaA and Asana BioSciences, LLC for the development of ADC product candidates utilizing Fleximer. The company was formerly known as Nanopharma Corp. and changed its name to Mersana Therapeutics, Inc.
Stocks similar to Mersana Therapeutics
Mersana Therapeutics in the news
Mersana Therapeutics Announces FDA Grant of Orphan Drug Designation to XMT-2056 for the Treatment of Gastric Cancer
Mersana announces FDA grant of orphan drug designation to XMT-2056
Mersana Therapeutics granted FDA orphan designation in gastric cancer treatment
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing
iGaming is now legal in Ontario. Find out which companies to keep an eye on with our list of 10 top online gaming stocks.Read more…
Enjoy perks like free trades and cash rewards when you open a stock trading account with these online brokers.Read more…
Here’s what you need to know about investing in the propane industry, including 3 popular propane stocks to watch.Read more…
More guides on Finder
Apps like Wealthsimple
Learn more about apps like Wealthsimple to find the best trading platform for your unique set of needs.
Online gaming stocks
iGaming is now legal in Ontario. Find out which companies to keep an eye on with our list of 10 top online gaming stocks.
How to buy Entain stock in Canada
Steps to owning and managing ENT stock, with 24-hour and historical pricing before you buy.
How to buy Kambi Group stock in Canada
Steps to owning and managing KAMBI stock, with 24-hour and historical pricing before you buy.
Best brokerage signup bonuses in 2022
Enjoy perks like free trades and cash rewards when you open a stock trading account with these online brokers.
How to buy Rush Street Interactive stock in Canada
Steps to owning and managing RSI stock, with 24-hour and historical pricing before you buy.
How to buy PointsBet stock in Canada
Steps to owning and managing PBTHF stock, with 24-hour and historical pricing before you buy.
How to buy Hanover Bancorp, Inc. (HNVR) stock in Canada when it goes public
Everything we know about the Hanover Bancorp, Inc. IPO, plus information on how to buy in.
How to buy PrimeBlock stock in Canada when it goes public
Everything we know about the PrimeBlock IPO, plus information on how to buy in.
How to buy Actelis Networks (ASNS) stock in Canada when it goes public
Everything we know about the Actelis Networks IPO, plus information on how to buy in.